2 бет - Ең жақсы Сүйек кемігінің биопсиясы дәрігерлері - ЖОҒ-55 дәрігерлер

Education & Expertise

• 1997 | Hacettepe University Faculty of Medicine – Medical Degree
• 2003 | Uludağ University Faculty of Medicine – Internal Medicine Specialization
• 2007 | Uludağ University Faculty of Medicine – Hematology Subspecialty

Professional Experience

• 1998 (May – September) | Practitioner, Dr. Salaha Health Center, Rize
• 1998 to 2003 | Research Assistant, Uludağ University Faculty of Medicine, Internal Medicine Department
• 2003 to 2007 | Hematology Subspecialist, Uludağ University Faculty of Medicine, Hematology Division
• 2007 to 2011 | Hematology Specialist, Bursa Ali Osman Sönmez Oncology Hospital (Compulsory Service)
• 2011 to 2013 | Hematology Specialist, Private Anadolu Health Center Bone Marrow Transplant Center, Gebze
• 2014 to 2015 | Assistant Professor, Yeditepe University Faculty of Medicine, Department of Internal Medicine
• 2015 to 2020 | Associate Professor, Yeditepe University Faculty of Medicine, Department of Internal Medicine
• 2020 to Present | Professor, Yeditepe University Faculty of Medicine, Department of Internal Medicine

Courses & Certifications

• Autologous and Allogeneic Stem Cell Transplantation Certificate
• Clinical Phytotherapy Application Certificate
• Flow Cytometry Experience Certificate
• EBMT Stem Cell Transplantation Course

Professional Memberships

• Turkish Medical Chamber
• Turkish Hematology Association (Full Member, No: 893)
• Turkish Therapeutic Apheresis Association (Current President)
• Geriatric Hematology Association
• Hematological Oncology Association
• EBMT (European Bone Marrow Transplantation)

Awards & Recognitions

• 2011 | 6th Turkish Therapeutic Apheresis Congress – Young Researcher Award

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Дәрігер Ходжкин емес лимфоманы емдеуде жетекші сарапшы болып табылады және қан ауруларын емдеуге маманданған. 30 жылдан астам тәжірибесі бар дәрігер Nordwest клиникасындағы гематология секторын басқарады, дамыған гематологиялық күтім мен зерттеулерге назар аударады.<\/p>

Prof. Dr. Mehmet Sait Buğdacı is a highly experienced physician specializing in Internal Medicine and Gastroenterology. He completed his medical education and specialty training at Istanbul University Cerrahpaşa Faculty of Medicine and Şişli Etfal Training and Research Hospital. His clinical interests include gastrointestinal diseases, endoscopic procedures, and clinical research. He has contributed to medical education through numerous scientific publications and textbooks and currently sees patients at Central Hospital.

Areas of Interest • Pediatric gastrointestinal surgery • Anorectal malformations and motility disorders • Minimally invasive pediatric surgery • Pediatric colorectal and pelvic floor disorders

Дәрігер Хадасса медициналық орталығында жоғары білікті балалар онкологиясы және гематоонкология маманы болып табылады, 2019-2020 жылдардағы Израильдегі ең үздік дәрігерлердің Forbes тізіміне енген. Педиатрия, балалар гематоонкологиясы және гаплоидентикалық сүйек кемігін трансплантациялау саласында жиырма жылдан астам тәжірибесі бар дәрігер осы саладағы көрнекті тұлға болып табылады.<\/p>

Дәрігер Тель-Авив университетінің түлегі және Израиль балалар гематологиясы және онкологиясы қоғамы, Израиль қатерлі ісік қауымдастығы, Халықаралық онкология қауымдастығы және Халықаралық балалар онкологиясы қоғамы сияқты кәсіби қауымдастықтарға белсенді қатысады. Негізгі қызығушылық салаларына ретинобластома, дәл медицина және балалар онкологиясы кіреді.<\/p>

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Dr. Boaz Liberman, MD, is an orthopedic oncologist and sarcoma surgeon for adults and children. He directs the Orthopedic Oncology Unit and serves as Vice Head of Orthopedic Surgery at Sheba Medical Center. His focus is limb-sparing cancer surgery with functional reconstruction. He performs complex joint reconstruction, revision arthroplasty, MRgFUS, and reconstruction after bone metastases.

Education and training: MD, Tel Aviv University. Orthopedic surgery residency, Sheba Medical Center. Fellowships in Adult Reconstruction at Mount Sinai Hospital, Toronto, and in Orthopedic Oncology at Mount Sinai Hospital and Princess Margaret Cancer Centre. He is board-certified in Orthopedic Surgery and in Orthopedic Oncology Surgery. He is a Clinical Instructor at Tel Aviv University. Memberships include the Israel Medical Association, Israel Orthopedic Association, AATB, and EATB. He also serves on national advisory committees. His research covers bone and soft tissue sarcomas, serum markers, imaging-guided therapies, MRI arthrography, and the biomechanics of bone treated with MRgFUS.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Дәрігер 1985 жылы Хаджеттепе медициналық мектебін бітіріп, 1990 жылы Эге университетінде ішкі аурулар маманы болды. Өз білімін жетілдіре отырып, дәрігер гематология саласында маманданып, 1995 жылы Жапонияның Миэ медициналық мектебінде Ph.D. дәрежесін алды. 1997 жылға қарай дәрігер Эге университетінде гематология бойынша доцент, содан кейін профессор болды. 2003 жылы дәрігер Қаратеңіз техникалық университетінде гематология профессоры ретінде жұмысын жалғастырды. 65-тен астам ғылыми мақалалар, 112 кездесу баяндамалары және 34 конференция презентациялары бар дәрігер гематология және сүйек кемігін трансплантациялау саласына қосқан үлесі үшін танылды.<\/p>

Дәрігер 1992 жылы Анкара университетінің медицина факультетін бітіріп, Улудағ университетінің медицина факультеті, балалар аурулары кафедрасында медицина маманы атанды. 2002 жылы дәрігер сол мекемеде балалар гематологиясы бойынша ассистент профессор болып қызмет атқарды.<\/p>

Дәрігер балалардағы қатерлі ісіктерді, лейкозды (лимфоманы), балалардағы қан кету ауруларын, тамырлардың бітелуін, анемияны емдеуді және темір мен витаминдердің жетіспеушілігін диагностикалау және емдеу бойынша маманданған.<\/p>

Күшті академиялық негізге ие дәрігер халықаралық рецензияланған журналдарда 15 мақала жариялап, халықаралық ғылыми кездесулерде 9 толық мәтін ұсынған, 3 кітап немесе кітап тарауын жазған және жергілікті рецензияланған журналдарда 8 мақала жариялаған.<\/p>